Showing results (2021-2030 of 6,794) with videos related to

Sort By:
Pageof 680
Clinical Therapeutics|August 16, 2021
Cost-effectiveness Analysis of Prophylaxis Versus On-demand Treatment for Children With Hemophilia B Without Inhibitors in ChinaGuoqing Liu, Qing Xin, Zhenping Chen, et al.
Clinical Therapeutics|September 14, 2021
Efficacy and Safety of Fenofibrate-Statin Combination Therapy in Patients With Inadequately Controlled Triglyceride Levels Despite Previous Statin Monotherapy: A Multicenter, Randomized, Double-blind, Phase IV StudyMyung Soo Park, Jong-Chan Youn, Eung Ju Kim, et al.
Clinical Therapeutics|May 2, 2020
Cost-effectiveness and Net Monetary Benefit of Durvalumab Consolidation Therapy Versus No Consolidation Therapy After Chemoradiotherapy in Stage III Non-small Cell Lung Cancer in the Italian National Health ServicePatrizio Armeni, Ludovica Borsoi, Giulia Fornaro, et al.
Clinical Therapeutics|January 1, 1988
Epididymitis after transurethral prostatectomyK Fujita, T Kimura, K Saito, et al.
Clinical Therapeutics|January 1, 1988
Mortality after transurethral prostatectomyK Fujita, A Munakata, T Sayama
Clinical Therapeutics|April 28, 2021
Novel and Emerging Electrophysiological Biomarkers of Diabetic Neuropathy and Painful Diabetic NeuropathyAnne Marshall, Uazman Alam, Andreas Themistocleous, et al.
Clinical Therapeutics|February 12, 2023
Impact of the COVID-19 Pandemic on the Prescribing of Antiasthmatic Treatments in Portugal: A Nationwide StudyTânia Magalhães Silva, Bernardo Sousa Pinto, Inês Cunha, et al.
Clinical Therapeutics|April 7, 2005
Double-blind, randomized, parallel, placebo-controlled study of ibuprofen effects on thromboxane B2 concentrations in aspirin-treated healthy adult volunteersByron Cryer, Roger G Berlin, Stephen A Cooper, et al.
Clinical Therapeutics|April 13, 2005
Review of ibandronate in the treatment of metastatic bone disease: experience from phase III trialsDebu Tripathy, Jean-Jacques Body, Bengt Bergström
Clinical Therapeutics|April 13, 2005
Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapyJames K Malone, Lisa F Kerr, Barbara N Campaigne, et al.
Pageof 680